 |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
| Designed by Vextura Web Development | ||
 |
Monthly Meetings |  |
|||||
| |||||||
|
MONTHLY MEETINGS: May Meeting
When: May 27, 2008
Where: Dukes Malibu
21150 Pacific Coast Hwy.
Malibu, CA 90045
(310) 670-3815
Dinner Hour Speaker: TBD
Dinner Hour Topic: Rembrandts in the Attic and Polishing the Crystal Ball: Old Bioactives with New Tricks and Novel Bioactives for Innovations
Educational Hour Speaker: Mindy S. Goldstein, Ph.D.
Educational Hour Topic: Demystifying INCI Nomenclature Education Hour Speaker for May Meeting TOPIC: Demystifying INCI Nomenclature
ABSTRACT:
Cosmetic labeling laws require that the ingredients in a preparation must be displayed clearly on the label. The accepted ingredient names are those that are monographed in the PCPC’s dictionary of cosmetic ingredients, under the guidelines for International Nomenclature of Cosmetic Ingredients (INCI). There are about 14,000 distinct INCI names in the 2006 11th edition of the Cosmetic Ingredient Dictionary. It is desirable for raw material suppliers to obtain an INCI name for each new cosmetic raw material as an integral part of commercialization. This mini-seminar will explain the rules of INCI nomenclature and the processes that are followed in assigning INCI names. We will describe the application procedure, typical topics of INCI committee deliberation, the assignment of an INCI name, and the stages that lead to publication of the ingredient monograph. We will address frequently asked questions, myths and common errors that are made in applying for INCI names. Participants can expect to gain useful insight into the operations and conventions that must be followed to expedite the assignment of an INCI name. BIO:  Dr. Goldstein received her B.S. with honors in Biochemistry, M.S. in Pathology and Ph.D. in Basic Medical Sciences from New York University in the area of UV and gamma radiation damage to DNA and DNA repair. She has been credited with more than eleven publications in scientific journals, and books and has been awarded patents in the area of encapsulation and controlled release. Dr. Goldstein has been an invited speaker at many scientific meetings and courses. She has been in the cosmetic industry since 1987 and is currently Executive Director, Research & Development, for The Estee Lauder Companies, Melville, NY. Her responsibilities include supplier contact for REACH activities, internal commercialization of new treatment actives for all of the Estee Lauder brands, troubleshooting formulation issues with active materials, encapsulation technology and identifying new platform technologies. Dr. Goldstein has previously held Directors positions in R & D at Bath & Body Works, Lipo Chemicals and Collaborative Laboratories. She is an active member of the Society of Cosmetic Chemists. In 1994, she was the Chair of the Long Island Chapter of the Society, the 1998 Chair of the Committee on Scientific Affairs and the 2002 National President of the Society of Cosmetic Chemists. Dr. Goldstein is editor and serves as a reviewer for the Journal of Cosmetic Science. She is a member of numerous professional and scientific organizations including the CTFA Nomenclature Committee. Dinner Hour Speaker for May Meeting TOPIC: Rembrandts in the Attic and Polishing the Crystal Ball: Old Bioactives with New Tricks and Novel Bioactives for Innovations
ABSTRACT:
Personal care items are cluttered with ingredient lists that are highly similar and rarely contain pioneering or even exclusive ingredients. Initially novel bioactives commonly enter the products landscape with fireworks in their first year, only to fizzle out into a yawn in years 2 and beyond. Much of the innovation that is performed in personal care products is capitalized by the ingredient manufacturer, NOT by the finished goods marketer. What enters into commerce is often YEARS after the bioactive enters into the community of science and patents. Think coenzyme Q10, creatine, ascorbic acid, melatonin, grape seed extract, lipoic acid, green tea extract. Long before these entered into commercial compositions their utility was known and accessible—if one looked in the right, rarefied spot. This presentation will explore “old” natural bioactive agents that have very recently described novel functionality, and novel natural bioactives that you haven’t heard or read about—yet—with intriguing and promising, consumer-relevant functionality. The type that stirs discussion at SCC beachside dinners and at cocktail parties among consumers looking for the next Blingier than Botox® product. Hear and see what may become a category creator or disrupter...perhaps one that can be exploited by attendees at this month’s meeting. BIO:
Coming Soon . . .
|
|
||||||
All rights Reserved.